The presence of the TXA2 receptor in lipid rafts of platelets is necessary for platelet activation by TXA2

被引:0
|
作者
Moscardo, Antonio [1 ]
Valles, Juana [1 ]
Madrid, Isabel [2 ]
Latorre, Ana [1 ]
Dasi, Angeles [1 ]
Teresa Santos, Maria [1 ]
机构
[1] Univ Hosp La Fe, Res Ctr, Valencia 46009, Spain
[2] Intens Care Unit, Valencia, Spain
关键词
D O I
10.1016/j.thromres.2012.08.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S103 / S103
页数:1
相关论文
共 50 条
  • [1] Flavonoids inhibit the platelet TxA2 signalling pathway and antagonize TxA2 receptors (TP) in platelets and smooth muscle cells
    Guerrero, Jose A.
    Navarro-Nunez, Leyre
    Lozano, Maria L.
    Martinez, Constantino
    Vicente, Vicente
    Gibbins, Jonathan M.
    Rivera, Jose
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (02) : 133 - 144
  • [2] ACUTE REDUCTION OF TXA2 PLATELET BINDING-SITES AFTER INVIVO ADMINISTRATION OF A TXA2 RECEPTOR INHIBITOR
    MODESTI, PA
    COLELLA, A
    CECIONI, I
    GENSINI, GF
    ABBATE, R
    SERNERI, GGN
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (04) : 439 - 443
  • [3] Antiplatelet action of losartan involves TXA2 receptor antagonism but not TXA2 synthase inhibition
    Chlopicki, S
    Koda, M
    Chabielska, E
    Buczko, W
    Gryglewski, RJ
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2000, 51 (04): : 715 - 722
  • [4] Mutations of the platelet thromboxane A2 (TXA2) receptor in patients characterized by the absence of TXA2-induced platelet aggregation despite normal TXA2 binding activity
    Higuchi, W
    Fuse, I
    Hattori, A
    Aizawa, Y
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (05) : 1528 - 1531
  • [5] PLATELET TXA2 SYNTHETASE INHIBITION AND TXA2 PROSTAGLANDIN ENDOPEROXIDE RECEPTOR BLOCKADE COMBINED IN ONE MOLECULE (R 68070)
    DECLERCK, F
    VANDEWIELE, R
    XHONNEUX, B
    VANGORP, L
    SOMERS, Y
    LOOTS, W
    BEETENS, J
    VANWAUWE, J
    FREYNE, E
    JANSSEN, PAJ
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 181 - 181
  • [6] THE ROLE OF PI TURNOVER IN TXA2-INDUCED PLATELET ACTIVATION - EFFECTS OF TXA2 ANTAGONISTS
    POLLOCK, WK
    MACINTYRE, DE
    EUROPEAN HEART JOURNAL, 1983, 4 : 4 - 4
  • [7] Mutagenic analysis of the platelet thromboxane A2(TXA2) receptor with platelet dysfunction characterized by the absence of TXA2-induced platelet aggregation in spite of normal TXA2 binding activity.
    Fuse, I
    Higuchi, W
    Sato, N
    Seki, Y
    Aizawa, Y
    THROMBOSIS AND HAEMOSTASIS, 1999, : 497 - 497
  • [8] PICOTAMIDE INHIBITS TXA2 PLATELET RECEPTORS
    MODESTI, PA
    COLELLA, A
    ABBATE, R
    SERNERI, GGN
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 554 - 554
  • [9] Lipid rafts in platelets: their role for TXA2-induced platelet activation
    Moscardo, A.
    Valles, J.
    Latorre, A.
    Madrid, I
    Santos, M. T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 633 - 633
  • [10] THROMBOXANE-A2 PROSTAGLANDIN ENDOPEROXIDE (TXA2/PG-END) RECEPTOR-BINDING PROPERTIES IN HUMAN PLATELETS OF RIDOGREL, A COMBINED TXA2 SYNTHASE INHIBITOR - TXA2/PG-END RECEPTOR ANTAGONIST
    HEYLEN, L
    DECLERCK, F
    SOMERS, Y
    LEYSEN, JE
    BLOOD COAGULATION & FIBRINOLYSIS, 1991, 2 (05) : 617 - 621